Bluejay Diagnostics (BJDX) Competitors $1.32 -0.06 (-4.35%) As of 02:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. LUCY, CODX, SSKN, POAI, LFWD, ICU, HSCS, AMIX, STRR, and SINTShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Innovative Eyewear (LUCY), Co-Diagnostics (CODX), Strata Skin Sciences (SSKN), Predictive Oncology (POAI), Lifeward (LFWD), SeaStar Medical (ICU), HeartSciences (HSCS), Autonomix Medical (AMIX), Star Equity (STRR), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors Innovative Eyewear Co-Diagnostics Strata Skin Sciences Predictive Oncology Lifeward SeaStar Medical HeartSciences Autonomix Medical Star Equity Sintx Technologies Bluejay Diagnostics (NASDAQ:BJDX) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations. Which has more volatility and risk, BJDX or LUCY? Bluejay Diagnostics has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 3.21, indicating that its stock price is 221% more volatile than the S&P 500. Is BJDX or LUCY more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to Innovative Eyewear's net margin of -443.18%. Innovative Eyewear's return on equity of -86.90% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -362.07% -299.10% Innovative Eyewear -443.18%-86.90%-81.36% Do insiders and institutionals hold more shares of BJDX or LUCY? 18.5% of Bluejay Diagnostics shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 0.1% of Bluejay Diagnostics shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger earnings & valuation, BJDX or LUCY? Bluejay Diagnostics has higher earnings, but lower revenue than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay DiagnosticsN/AN/A-$7.72M-$125.15-0.01Innovative Eyewear$1.71M5.66-$7.77M-$3.99-0.53 Does the media prefer BJDX or LUCY? In the previous week, Bluejay Diagnostics had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 5 mentions for Bluejay Diagnostics and 3 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.97 beat Bluejay Diagnostics' score of 0.45 indicating that Innovative Eyewear is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bluejay Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryInnovative Eyewear beats Bluejay Diagnostics on 7 of the 12 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.97M$6.87B$5.58B$9.82BDividend YieldN/A1.31%4.62%4.12%P/E Ratio-0.0124.7730.1825.60Price / SalesN/A70.17447.95105.60Price / CashN/A21.6737.7558.93Price / Book0.375.628.425.99Net Income-$7.72M$176.29M$3.26B$264.94M7 Day Performance-10.20%3.23%3.70%2.47%1 Month Performance-18.01%-1.15%4.00%1.33%1 Year Performance-91.10%11.51%35.79%28.75% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.6648 of 5 stars$1.32-4.3%N/A-91.7%$1.97MN/A-0.019Earnings ReportShort Interest ↑Gap DownLUCYInnovative Eyewear0.8202 of 5 stars$2.01+3.6%N/A-51.0%$8.88M$1.71M-0.509Short Interest ↓CODXCo-Diagnostics4.5712 of 5 stars$0.26+3.4%$5.50+2,042.6%-77.8%$8.33M$3.91M-0.22100Short Interest ↓SSKNStrata Skin Sciences2.5635 of 5 stars$1.93-1.0%$6.00+210.9%-30.6%$8.13M$33.62M-0.85120News CoverageShort Interest ↑POAIPredictive Oncology2.0268 of 5 stars$0.77+1.6%$3.00+287.6%-12.2%$7.79M$1.62M-0.2530News CoverageEarnings ReportGap UpLFWDLifeward2.7764 of 5 stars$0.70+0.5%$9.00+1,185.7%-77.4%$7.67M$25.66M-0.2360Trending NewsICUSeaStar Medical0.2979 of 5 stars$0.70+6.4%N/A-88.0%$7.34M$428K-0.202Earnings ReportShort Interest ↑HSCSHeartSciences3.4114 of 5 stars$3.30+8.2%$13.00+293.9%+7.0%$6.85M$4.35K-0.3510Short Interest ↓Gap UpAMIXAutonomix Medical3.165 of 5 stars$1.34-3.6%$16.50+1,131.3%-91.4%$6.78MN/A-0.181News CoveragePositive NewsEarnings ReportShort Interest ↑STRRStar Equity2.9675 of 5 stars$1.99-1.5%$5.00+151.3%-38.5%$6.51M$53.36M-0.58460News CoverageAnalyst ForecastSINTSintx Technologies2.8356 of 5 stars$2.67+11.3%$28.00+948.7%-28.4%$6.02M$2.89M-0.0540Short Interest ↓Gap Up Related Companies and Tools Related Companies Innovative Eyewear Alternatives Co-Diagnostics Alternatives Strata Skin Sciences Alternatives Predictive Oncology Alternatives Lifeward Alternatives SeaStar Medical Alternatives HeartSciences Alternatives Autonomix Medical Alternatives Star Equity Alternatives Sintx Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access